Skip to content
healthcare.dev

Azilect

NDC 68546-229, Rasagiline mesylate, tablet, from Teva Neuroscience, Inc..

Product NDC
68546-229
Status
Listed
Labeler
Teva Neuroscience, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021641
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68546-229 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE1 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
68546-229-566854602295630 TABLET in 1 BOTTLE (68546-229-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a40d0e73-3f9f-4b01-979d-402c9cdaeb60

Use it

Look up 68546-229 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68546-229 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68546-229. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.